Immunological evidence for interactions between the first, second, and fifth conserved domains of the gp120 surface glycoprotein of human immunodeficiency virus type 1 - PubMed (original) (raw)

Immunological evidence for interactions between the first, second, and fifth conserved domains of the gp120 surface glycoprotein of human immunodeficiency virus type 1

J P Moore et al. J Virol. 1994 Nov.

Abstract

We have used a combination of genetic and immunological techniques to explore how amino acid substitutions in the second conserved (C2) domain of gp120 from human immunodeficiency virus type 1 (HIV-1) affect the conformation of the protein. It was reported previously (R. L. Willey, E. K. Ross, A. J. Buckler-White, T. S. Theodore, and M. A. Martin. J. Viol. 63:3595-3600, 1989) that an asparagine-glutamine (N/Q) substitution at C2 residue 267 of HIV-1 NL4/3 reduced virus infectivity, but that infectivity was restored by a compensatory amino acid change (serine-glutamine; S/N) at residue 128 in the C1 domain. Here we show that the 267 N/Q substitution causes the abnormal exposure of a segment of C1 spanning residues 80 to 120, which compromises the integrity of the CD4-binding site. The reversion substitution at residue 128 restores the normal conformation of the C1 domain and recreates a high-affinity CD4-binding site. The gp120 structural perturbation caused by changes in C2 extends also to the C5 domain, and we show by immunological analysis that there is a close association between areas of the C1 and C5 domains. This association might be important for forming a complex binding site for gp41 (E. Helseth, U. Olshevsky, C. Furman, and J. Sodroski. J. Virol. 65:2119-2123, 1991). Segments of the C1 and C2 domains are predicted to form amphipathic alpha helices. We suggest that these helices might be packed together in the core of the folded gp120 molecule, that the 267 N/Q substitution disrupts this interdomain association, and that the 128 S/N reversion substitution restores it.

PubMed Disclaimer

Cited by

Reconstruction of a polyclonal ADCC antibody repertoire from an HIV-1 non-transmitting mother.
Yaffe ZA, Ding S, Sung K, Chohan V, Marchitto L, Doepker L, Ralph D, Nduati R, Matsen FA 4th, Finzi A, Overbaugh J. Yaffe ZA, et al. iScience. 2023 Apr 26;26(5):106762. doi: 10.1016/j.isci.2023.106762. eCollection 2023 May 19. iScience. 2023. PMID: 37216090 Free PMC article.
A Structural Update of Neutralizing Epitopes on the HIV Envelope, a Moving Target.
Parker Miller E, Finkelstein MT, Erdman MC, Seth PC, Fera D. Parker Miller E, et al. Viruses. 2021 Sep 5;13(9):1774. doi: 10.3390/v13091774. Viruses. 2021. PMID: 34578355 Free PMC article. Review.
HIV-1 Envelope Glycosylation and the Signal Peptide.
Lambert GS, Upadhyay C. Lambert GS, et al. Vaccines (Basel). 2021 Feb 19;9(2):176. doi: 10.3390/vaccines9020176. Vaccines (Basel). 2021. PMID: 33669676 Free PMC article. Review.
HIV-1 Envelope Glycoprotein Amino Acids Signatures Associated with Clade B Transmitted/Founder and Recent Viruses.
Kafando A, Martineau C, El-Far M, Fournier E, Doualla-Bell F, Serhir B, Kazienga A, Sangaré MN, Sylla M, Chamberland A, Charest H, Tremblay CL. Kafando A, et al. Viruses. 2019 Nov 1;11(11):1012. doi: 10.3390/v11111012. Viruses. 2019. PMID: 31683782 Free PMC article.
A New Family of Small-Molecule CD4-Mimetic Compounds Contacts Highly Conserved Aspartic Acid 368 of HIV-1 gp120 and Mediates Antibody-Dependent Cellular Cytotoxicity.
Ding S, Grenier MC, Tolbert WD, Vézina D, Sherburn R, Richard J, Prévost J, Chapleau JP, Gendron-Lepage G, Medjahed H, Abrams C, Sodroski J, Pazgier M, Smith AB 3rd, Finzi A. Ding S, et al. J Virol. 2019 Nov 26;93(24):e01325-19. doi: 10.1128/JVI.01325-19. Print 2019 Dec 15. J Virol. 2019. PMID: 31554684 Free PMC article.

References

1. Biophys J. 1968 Jan;8(1):29-39 - PubMed
1. AIDS Res Hum Retroviruses. 1994 Apr;10(4):371-81 - PubMed
1. J Mol Biol. 1984 Oct 15;179(1):125-42 - PubMed
1. Science. 1986 Jan 24;231(4736):382-5 - PubMed
1. Cell. 1986 Jun 6;45(5):637-48 - PubMed

Immunological evidence for interactions between the first, second, and fifth conserved domains of the gp120 surface glycoprotein of human immunodeficiency virus type 1 - PubMed (original) (raw)